GlaxoSmithKline

GSK-GB:LON

Pharmaceuticals: Major

Market Cap

MEGA cap

Share Price ↑

$42.73 (0.13%)

YTD Return ↑

0.13%

since start of 2019

P/E Ratio

18.37

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data Privacy
Consumer Health
Employee Satisfaction
Workplace Safety
Corp Gov
Ethical Practices
Conflict Materials
Forced Labor
Gender Diversity

Legend

About

Pharmaceuticals: Major Founded 1999

GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, the United Kingdom.

Name	Title	Gender
Simon Dingemans	Chief Financial Officer & Executive Director	Male
Philip Roy Hampton, MBA	Non-Executive Chairman	Male
Dan Troy	Senior Vice President & General Counsel	Male
Patrick J. T. Vallance, MD	Executive Director, President-R&D	Male
Claire Thomas	Senior Vice President-Human Resources	Female
Emma Walmsley	Chief Executive Officer & Executive Director	Female
Ziba Shamsi	Head-Investor Relations	Female

GlaxoSmithKline

GSK-GB:LON

Pharmaceuticals: Major

About

Headquarters

Executives

Mindful Investing Summary

GlaxoSmithKline - Competitors and Related Companies